22.19k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
|Watchlist||Change today||1-month return||1-year return||Total return|
|The Fight Against COVID19||-2.33%||-||-||-|
|Symbol||Company name||Last price||Change||% change||Market time||Volume||Avg vol (3-month)||Market cap|
|JNJ||Johnson & Johnson||163.72||+0.32||+0.20%||4:00 pm GMT-4||4.30M||5.84M||430.99B|
|PFE||Pfizer Inc.||43.16||+0.30||+0.70%||4:02 pm GMT-4||17.18M||32.09M||241.98B|
|ABBV||AbbVie Inc.||109.14||+0.38||+0.35%||4:02 pm GMT-4||4.61M||7.10M||192.87B|
|MRNA||Moderna, Inc.||326.54||-13.03||-3.84%||4:00 pm GMT-4||7.78M||16.55M||131.81B|
|SNY||Sanofi||49.92||+0.71||+1.44%||4:00 pm GMT-4||2.16M||2.02M||125.32B|
|GSK||GlaxoSmithKline plc||39.77||+0.22||+0.56%||4:00 pm GMT-4||4.82M||3.69M||100.06B|
|GILD||Gilead Sciences, Inc.||67.24||+0.25||+0.37%||4:00 pm GMT-4||4.50M||6.20M||84.31B|
|BNTX||BioNTech SE||278.34||-8.02||-2.80%||4:00 pm GMT-4||3.54M||4.17M||67.50B|
|REGN||Regeneron Pharmaceuticals, Inc.||572.36||+2.99||+0.53%||4:00 pm GMT-4||492.96k||781.19k||61.22B|
|TAK||Takeda Pharmaceutical Company Limited||14.07||+0.05||+0.36%||4:00 pm GMT-4||1.50M||2.18M||44.25B|
|NVAX||Novavax, Inc.||134.56||-4.23||-3.05%||4:00 pm GMT-4||3.11M||5.38M||10.02B|
|VIR||Vir Biotechnology, Inc.||40.21||+0.28||+0.70%||4:00 pm GMT-4||419.70k||975.86k||5.25B|
|INO||Inovio Pharmaceuticals, Inc.||6.74||-0.30||-4.26%||4:00 pm GMT-4||4.07M||4.11M||1.42B|
The United States has administered 412,856,169 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 503,521,625 doses, the U.S. Centers for Disease Control and Prevention said. Those figures are up from the 411,963,025 vaccine doses the CDC said had gone into arms by Friday out of 501,613,665 doses delivered. The CDC tally includes two-dose vaccines from Moderna MRNA.O and Pfizer/BioNTech PFE.N, BNTX.O, as well as Johnson & Johnson's JNJ.N one-shot vaccine.
If you're investing in a dividend stock, it's important to balance yield with risk. While you don't want to be too aggressive by looking for 10% dividend yields, you don't want to settle for nominal payouts either. Two stocks that pay at least 3% and are fairly safe buys over the long haul are Gilead Sciences (NASDAQ: GILD) and Campbell Soup (NYSE: CPB).
Earlier this month, Merck (NYSE: MRK) announced it was ending clinical trials of its antiviral pill candidate for treating COVID-19, molnupiravir, on account of the potential therapy's high level of effectiveness. Take Gilead Sciences' (NASDAQ: GILD) antiviral drug, remdesivir. Will Merck's drug follow a similar or better path?